PhD MBBS MIPH BAppSc FRACP
Dr Anthony Byrne is a thoracic physician and researcher with a strong interest in respiratory infections, asthma and structural lung disease. His doctoral studies focused on the link between tuberculosis and chronic respiratory disease including asthma and chronic obstructive pulmonary disease among patients in Lima, Peru.
Dr Byrne is a staff specialist respiratory physician at St Vincent’s public and private hospitals and has consulting rooms at St Vincent’s Clinic, Darlinghurst. He is a Cochrane author and associate editor with the “Cochrane Clinical Answers” initiative, dedicated to providing bite-size, clinician-focused summaries of high-quality systematic reviews.
Staff Specialist in Respiratory Medicine, St Vincent’s Public and Private Hospitals, Sydney.
Staff Specialist in Respiratory Medicine, Blacktown Public Hospital, Sydney.
Conjoint Associate Lecturer of Medicine: St Vincent’s Clinical School, UNSW.
Author, Cochrane Clinical Answers, Cochrane Review Group
Respiratory Physician: St Vincent’s Clinic suite 806, Victoria St, Sydney (Private Practice)
Past 5 Years
1) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. PhD scholarship. (2014-2015).Chronic Respiratory Disease among Successfully Treated Tuberculosis Patients of Lima, Peru. Byrne AL, Marais BJ, Marks GB. $50,000.
2) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. Seed Funding. (2014). Byrne AL, Marais BJ, Mitnick CD, Marks GB. Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis. A population-based cohort study in Lima, Peru. $25,000.
3) University of Sydney Postgraduate Research Support Scheme (2014, 2015). Byrne AL. Pulmones Post TB (Lungs after tuberculosis). Project support $12,000.
4) Woolcock Institute of Medical Research Fund (2015, 2016). Byrne AL. Marais BJ, Marks GB “Pulmones Post TB” (Lungs after tuberculosis). Project support $15,000.
5) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. Seed Funding. (2017). Byrne AL, Marais BJ, Marriott D. The use of therapeutic drug monitoring to improve clinical outcomes for patients with pulmonary tuberculosis; a pilot study. $25,000
1) Thoracic Society of Australia and New Zealand, New South Wales Branch. (TSANZ). Elected executive committee member. (2017-ongoing).
2) New South Wales Tuberculosis Program. Expert panel member (2017- ongoing).
3) St Vincent’s Hospital Drug Committee member (2018- ongoing).
4) The V-QUIN MDR TRIAL: Expert Panel Member to review adverse events. The V-QUIN trial is a multicentre, randomised controlled trial to assess the efficacy of 6 months of levofloxacin preventative therapy for household contacts of multidrug resistant tuberculosis patients in Vietnam.
5) St Vincent’s hospital tuberculosis working group. Founding member (2015-ongoing).
• NHMRC Tuberculosis Centre of Research Excellence • International Union Against Tuberculosis and Lung Disease
• Harvard Medical School Global Health and Social Medicine Tuberculosis Research Group
• Partners In Health (Socios En Salud Sucursal, Peru) Principal Investigator
• Associate Investigator International Research and Development (IRD; a global health delivery and research organization based in Pakistan).
Journals: Respirology, BMC Respiratory, International Journal of chronic obstructive pulmonary disease, Journal of Thoracic Disease & others.
Undergraduate, postgraduate, junior medical officer (JMO) and basic & advanced trainee teaching and supervision.
Examiner: undergraduate exams (FRACP clinical exam), ATs.
Research supervision including AT projects.